OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes research articles, technical reports and invited topical reviews. Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 11.8 days from acceptance to publication (median values for papers published in this journal in the second half of 2021, 1-2 days of FREE language polishing time is also included in this period).
Natural Products and Their Bioactive Compounds for Treatment of Neurodegenerative Brain Disorder
Submission Deadline: May 31, 2023 (Open) Submit Now
Dr. Talha Bin Emran, Associate Professor
Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, 4381, Bangladesh
Research interests: Natural Product Chemistry, Alternative Medicine, Phytochemistry, Bioinformatics, Immunology, Vaccinology.
About This Topic
For many years, natural products have been recognized as an important source of therapeutic compounds. In particular, the use of plant-derived active substances for use in neurodegenerative brain disorders natural products has been in use since the start of modern medicine. Nature's medicinal properties have historically correlated with their chemical, biochemical, and synthetic activities. These natural products' unique properties are thus being harnessed by modern scientific advancement in molecular and cellular biology as well as analytical chemistry and pharmacology in order to take full advantage of these products' chemical and structural diversity and biodiversity as well as the potential therapeutic effects of these products. The rearrangement of chemical entities or structural isomers of naturally existing products is often used in drug design units to develop novel compounds that can be used in clinical trials.
The discovery of new pharmaceutical drug candidates may be aided by an integrated method that combines modern genetic sequencing with biosynthetic pathway management. Understanding how structural confirmations or functionality relate to molecular activity is crucial to the success of natural products in previous and current medication research. Nature continues to produce biological diversity, which is vital to target, especially given the lack of results from combinatorial techniques. If the environment continues to yield untapped resources, we may be able to discover novel anti-infective agents.
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.